目的: 探讨我国创新医药的多层次保障体系建设。方法: 基于理论分析与政策经验,探讨基本医保对创新医药的支持作用和局限性,提出专项保障机制对于创新医药初期临床导入阶段的风险管控和财务支付的重要意义,并分析了商业医保与专项基金这两种创新医药专项保障机制运行模式的特点与利弊。结论: 建立创新医药的专项保障机制,理顺其与基本医保的衔接配合,从而建立多层次保障体系,对于我国创新医药的发展和应用具有重要意义。

Objective: The paper explores the construction of a multi-level security system for innovative pharmaceuticals in China. Methods: Based on theoretical analysis and policy experience, this paper discussed the role and limitations of basic medical insurance supporting innovative drugs, put forward the importance of the special security mechanism for risk control and financial payment in the initial clinical introduction stage of innovative drugs, and analyzed the characteristics, advantages and disadvantages of the operation modes of commercial medical insurance and special funds. Conclusion: It is of great significance for the development and application of innovative drugs in China to establish a special security mechanism for innovative drugs and clarify its connection and cooperation with basic medical insurance, so as to establish a multi-level security system.